Fibrocell Science (FCSC) Misses Q4 EPS by 23c

Fibrocell Science (NASDAQ: FCSC) reported Q4 EPS of ($0.40), $0.23 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $82 thousand versus the consensus estimate of $80 thousand.

For earnings history and earnings-related data on Fibrocell Science (FCSC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15